V Glib Met 500mg/0.2mg Tablet SR
Marketer
Aamorb Pharmaceuticals Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview V Glib Met 500mg/0.2mg Tablet SR
VGlibMet 500mg/0.2mg Extended-Release tablets are an antidiabetic medication combining two drugs to manage type 2 diabetes in adults. This combination therapy helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Potential side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes; these are typically transient and self-limiting. Persistent or concerning side effects warrant medical attention. Your doctor can offer management strategies. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your doctor.
Uses of V Glib Met 500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of V Glib Met 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg/0.2mg V Glib Met SR tablet whole; do not crush, chew, or break it. Administer this medication with food.
Common Side effects of V Glib Met 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use V Glib Met 500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The V Glib Met 500mg/0.2mg sustained-release tablet should be administered with a meal.
How V Glib Met 500mg/0.2mg Tablet SR works:
Each V Glib Met 500mg/0.2mg extended-release tablet contains a dual-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and V Glib Met 500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of V Glib Met 500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination of 500mg V Glib and 0.2mg Met may pose a risk to breastfeeding infants. Available data from human studies indicate potential transfer of the medication into breast milk, with the possibility of adverse effects on the nursing child.
DrivingSAFE
Driving ability is generally unaffected by V Glib Met 500mg/0.2mg SR tablets. Nevertheless, patients should be aware of the potential for low blood sugar (hypoglycemia) if this medication is taken alongside other diabetes treatments like sulfonylureas, insulin, or repaglinide.
KidneyCAUTION
Patients with impaired kidney function should use V Glib Met 500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of V Glib Met 500mg/0.2mg sustained-release tablets to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take V Glib Met 500mg/0.2mg Tablet SR :
Should you forget to take your V Glib Met 500mg/0.2mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About V Glib Met 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Medication for diabetes |
3,018 People bought this recently